Cargando…
Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effo...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062114/ https://www.ncbi.nlm.nih.gov/pubmed/21455416 http://dx.doi.org/10.4103/0253-7613.75661 |
_version_ | 1782200690969411584 |
---|---|
author | Kaur, Sharminder Kapoor, Vinod Mahajan, Rajiv Lal, Mohan Gupta, Seema |
author_facet | Kaur, Sharminder Kapoor, Vinod Mahajan, Rajiv Lal, Mohan Gupta, Seema |
author_sort | Kaur, Sharminder |
collection | PubMed |
description | BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effort to fill up these lacunae. MATERIALS AND METHODS: A prospective, observational study registering 966 indoor cardiology patients according to predetermined inclusion and exclusion criteria was conducted for one year. ADR profile was noted by spontaneous reporting and intensive monitoring. Naranjo ADR probability scale was used to establish the causality. RESULTS: A total of 208 ADRs were reported from 188 patients (19.5%). Of these 188 patients, 62 patients (33%) were hospitalized primarily due to the development of ADRs, while 126 (67%) patients developed ADRs during hospital stay. Nitrates were the most common offender drug group (17.8%). CONCLUSION: Development of ADR in one of every five cardiac patient points toward a grave situation, but a higher incidence of Type A reactions in cardiology department means that these can be avoided. |
format | Text |
id | pubmed-3062114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-30621142011-03-31 Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease Kaur, Sharminder Kapoor, Vinod Mahajan, Rajiv Lal, Mohan Gupta, Seema Indian J Pharmacol Research Article BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effort to fill up these lacunae. MATERIALS AND METHODS: A prospective, observational study registering 966 indoor cardiology patients according to predetermined inclusion and exclusion criteria was conducted for one year. ADR profile was noted by spontaneous reporting and intensive monitoring. Naranjo ADR probability scale was used to establish the causality. RESULTS: A total of 208 ADRs were reported from 188 patients (19.5%). Of these 188 patients, 62 patients (33%) were hospitalized primarily due to the development of ADRs, while 126 (67%) patients developed ADRs during hospital stay. Nitrates were the most common offender drug group (17.8%). CONCLUSION: Development of ADR in one of every five cardiac patient points toward a grave situation, but a higher incidence of Type A reactions in cardiology department means that these can be avoided. Medknow Publications 2011-02 /pmc/articles/PMC3062114/ /pubmed/21455416 http://dx.doi.org/10.4103/0253-7613.75661 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kaur, Sharminder Kapoor, Vinod Mahajan, Rajiv Lal, Mohan Gupta, Seema Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title | Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title_full | Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title_fullStr | Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title_full_unstemmed | Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title_short | Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
title_sort | monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062114/ https://www.ncbi.nlm.nih.gov/pubmed/21455416 http://dx.doi.org/10.4103/0253-7613.75661 |
work_keys_str_mv | AT kaursharminder monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease AT kapoorvinod monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease AT mahajanrajiv monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease AT lalmohan monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease AT guptaseema monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease |